Sermorelin.com, a telehealth platform specializing in physician-supervised peptide therapy, today announced the launch of a ...

Sermorelin.com Unveils Telehealth Peptide Treatment for Lean Mass Preservation Sheridan, United States - February 27, ...

From enhancing wound healing to combating neurodegeneration and cancer, growth hormone-releasing hormone and its analogs reveal groundbreaking roles that could redefine future therapies. Study: Growth ...

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth hormone secretagogues heading into 2026. CHEYENNE, WY, Jan. 09, ...

A new research paper was published in Oncotarget's Volume 15 on April 8, 2024, entitled, "Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia." ...

Theratechnologies entered a definitive agreement to be acquired by Future Pak. We review the technology behind Tesamorelin, their main product. Targeting the GHRH pathway has provided interesting ...

The Red & Black is a 501c3 nonprofit. Please consider a one-time gift or become a monthly supporter. Cancel anytime. Sermorelin is a synthetic peptide analog of growth hormone‑releasing hormone (GHRH) ...

During sleep, the brain produces growth hormone to help build muscle and bone and reduce fat. UC Berkeley research in mice reveals the brain circuits that regulate growth hormone release, along with a ...

Sermorelin is a synthetic form of growth hormone-releasing hormone (GHRH), used to raise levels of human growth hormone (hGH). It’s currently not available in the U. S. as an FDA-approved medication, ...